Role of Glutamate 64 in the Activation of the Prodrug 5-Fluorocytosine by Yeast Cytosine Deaminase

被引:9
作者
Wang, Jifeng [1 ]
Sklenak, Stepan [2 ]
Liu, Aizhuo [1 ]
Felczak, Krzysztof [1 ]
Wu, Yan [1 ]
Li, Yue [1 ]
Yan, Honggao [1 ]
机构
[1] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA
[2] Acad Sci Czech Republic, J Heyrovsky Inst Phys Chem, CR-18223 Prague, Czech Republic
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
TRANSITION-STATE ANALOG; BARRIER HYDROGEN-BOND; SIDE-CHAIN AMIDES; MOLECULAR-ORBITAL METHOD; LARGE PROTEINS; GEOMETRY OPTIMIZATION; GENE-THERAPY; ENZYME/PRODRUG THERAPY; SEMIEMPIRICAL METHODS; CATALYTIC MECHANISM;
D O I
10.1021/bi201540z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Yeast cytosine deaminase (yCD) catalyzes the hydrolytic deamination of cytosine to uracil as well as the deamination of the prodrug 5-fluorocytosine (5FC) to the anticancer drug 5-fluorouracil. In this study, the role of Glu64 in the activation of the prodrug 5FC was investigated by site-directed mutagenesis, biochemical, nuclear magnetic resonance (NMR), and computational studies. Steady-state kinetics studies showed that the mutation of Glu64 causes a dramatic decrease in k(cat) and a dramatic increase in K, indicating Glu64 is important for both binding and catalysis in the activation of 5FC. (19)F NMR experiments showed that binding of the inhibitor 5-fluoro-1H-pyrimidin-2-one (5FPy) to the wild-type yCD causes an upfield shift, indicating that the bound inhibitor is in the hydrated form, mimicking the transition state or the tetrahedral intermediate in the activation of 5FC. However, binding of 5FPy to the E64A mutant enzyme causes a downfield shift, indicating that the bound 5FPy remains in an unhydrated form in the complex with the mutant enzyme. (1)H and (15)N NMR analysis revealed trans-hydrogen bond D/H isotope effects on the hydrogen of the amide of G1u64, indicating that the carboxylate of Glu64 forms two hydrogen bonds with the hydrated 5FPy. ONIOM calculations showed that the wild-type yCD complex with the hydrated form of the inhibitor 1H-pyrimidin-2-one is more stable than the initial binding complex, and in contrast, with the E64A mutant enzyme, the hydrated inhibitor is no longer favored and the conversion has a higher activation energy, as well. The hydrated inhibitor is stabilized in the wild-type yCD by two hydrogen bonds between it and the carboxylate of Glu64 as revealed by (1)H and (15)H NMR analysis. To explore the functional role of Glu64 in catalysis, we investigated the deamination of cytosine catalyzed by the E64A mutant by ONIOM calculations. The results showed that without the assistance of Glu64, both proton transfers before and after the formation of the tetrahedral reaction intermediate become partially rate-limiting steps. The results of the experimental and computational studies together indicate that Glu64 plays a critical role in both the binding and the chemical transformation in the conversion of the prodrug 5FC to the anticancer drug 5-fluorouracil.
引用
收藏
页码:475 / 486
页数:12
相关论文
共 51 条
[1]  
Aghi M, 2000, J GENE MED, V2, P148, DOI 10.1002/(SICI)1521-2254(200005/06)2:3<148::AID-JGM105>3.0.CO
[2]  
2-Q
[3]   DENSITY-FUNCTIONAL THERMOCHEMISTRY .3. THE ROLE OF EXACT EXCHANGE [J].
BECKE, AD .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (07) :5648-5652
[4]  
Both GW, 2009, CURR OPIN MOL THER, V11, P421
[5]   Role of glutamate-104 in generating a transition state analogue inhibitor at the active site of cytidine deaminase [J].
Carlow, DC ;
Short, SA ;
Wolfenden, R .
BIOCHEMISTRY, 1996, 35 (03) :948-954
[6]   MAJOR CONTRIBUTION OF A CARBOXYMETHYL GROUP TO TRANSITION-STATE STABILIZATION BY CYTIDINE DEAMINASE - MUTATION AND RESCUE [J].
CARLOW, DC ;
SMITH, AA ;
YANG, CC ;
SHORT, SA ;
WOLFENDEN, R .
BIOCHEMISTRY, 1995, 34 (13) :4220-4224
[7]   The deuterium isotope effect on the NMR signal of the low-barrier hydrogen bond in a transition-state analog complex of chymotrypsin [J].
Cassidy, CS ;
Lin, J ;
Frey, PA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (02) :789-792
[8]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[9]   LOW-BARRIER HYDROGEN-BONDS AND ENZYMATIC CATALYSIS [J].
CLELAND, WW ;
KREEVOY, MM .
SCIENCE, 1994, 264 (5167) :1887-1890
[10]   The low barrier hydrogen bond in enzymatic catalysis [J].
Cleland, WW ;
Frey, PA ;
Gerlt, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (40) :25529-25532